To confirm the low prevalence of true SFs in TP53, we analyzed data from 50 cases of paired tumor–normal NGS assay, of which 30 patients underwent a tumor-only NGS assay in parallel (Supplementary Fig. 1). Here, TP53 is linked to neoplasm.